Ionis Pharmaceuticals, Inc. (LON:0JDI)
73.14
+0.64 (0.88%)
At close: Oct 17, 2025
Ionis Pharmaceuticals Employees
Ionis Pharmaceuticals had 1,069 employees as of December 31, 2024. The number of employees increased by 142 or 15.32% compared to the previous year.
Employees
1,069
Change (1Y)
142
Growth (1Y)
15.32%
Revenue / Employee
644.59K GBP
Profits / Employee
-183.13K GBP
Market Cap
8.70B
Employees Chart
Employees History
Date | Employees | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 1,069 | 142 | 15.32% |
Dec 31, 2023 | 927 | 131 | 16.46% |
Dec 31, 2022 | 796 | 136 | 20.61% |
Dec 31, 2021 | 660 | -97 | -12.81% |
Dec 31, 2020 | 757 | -60 | -7.34% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
Company Name | Employees |
---|---|
AstraZeneca | 94,300 |
GSK plc | 68,629 |
Haleon | 24,561 |
Smith & Nephew | 17,349 |
Spire Healthcare Group | 15,703 |
ConvaTec Group | 10,489 |
Hikma Pharmaceuticals | 9,500 |
Genus | 3,190 |
Ionis Pharmaceuticals News
- 3 days ago - Insider Sell Alert: B Parshall Sells 5,000 Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 3 days ago - Morgan Stanley Raises Price Target for Ionis Pharmaceuticals (IONS) | IONS Stock News - GuruFocus
- 3 days ago - Ionis to hold third quarter 2025 financial results webcast - Business Wire
- 11 days ago - Insider Sell: Brett Monia Sells Shares of Ionis Pharmaceuticals Inc (IONS) - GuruFocus
- 11 days ago - Ionis Pharmaceuticals, Inc. (IONS) Shareholder/Analyst Call - Slideshow - Seeking Alpha
- 11 days ago - Needham Raises Price Target on Ionis Pharmaceuticals (IONS) to $78 | IONS Stock News - GuruFocus
- 11 days ago - Oppenheimer Raises Ionis Pharmaceuticals (IONS) Price Target to $90 | IONS Stock News - GuruFocus
- 11 days ago - JP Morgan Boosts Ionis Pharmaceuticals (IONS) with Upgrade and Price Target Increase - GuruFocus